Mulmit

Evofem Biosciences, Inc.Evofem Biosciences, Inc.

EVFM OTC

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-3120,183,0003,372,000391,0000
2024-12-3119,363,000-7,676,000-8,860,000-0.11
2023-12-3118,218,000-17,847,00052,979,0000.05
2022-12-3116,837,000-84,124,000-76,698,000-167.42

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2024-01-12Zhang YanCFO104
2023-12-21Kamdar Kim P.10
2022-12-31File Justin J.Chief Financial Officer30,000
2022-12-31PELLETIER SAUNDRA LChief Executive Officer50,000
2022-05-27PELLETIER SAUNDRA LChief Executive Officer141,000
2022-05-04O'Brien Anthony Stephen6,000
2022-05-04Kamdar Kim P.6,000
2022-05-04Rutherford Colin6,000
2022-05-04Rarick Lisa Dale6,000
2022-05-04Greer Gillian6,000
2022-02-18Fitzpatrick Alexander AGeneral Counsel and Secretary300,000
2022-02-18Fitzpatrick Alexander AGeneral Counsel and Secretary300,000

8-K events

FiledItems
2026-07-20Regulation FD disclosure · Financial statements and exhibits
2026-07-14Entry into a material agreement · Creation of a direct financial obligation · Financial statements and exhibits
2026-05-18Results of operations · Financial statements and exhibits
2026-04-30Entry into a material agreement · Regulation FD disclosure · Financial statements and exhibits
2026-04-16Entry into a material agreement · Financial statements and exhibits
2026-03-19Termination of a material agreement · Financial statements and exhibits
2026-03-11Results of operations · Regulation FD disclosure · Financial statements and exhibits
2026-01-12Regulation FD disclosure · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Pharmaceutical Preparations — 같은 업종, 그리고 규모가 비슷한 기업Pharmaceutical Preparations — and other companies of a similar size

SEC가 같은 업종(Pharmaceutical Preparations)으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Pharmaceutical Preparations) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.